(4---1-)- Ӣ 4-chlorobutylsulfonylbenzene ʽ C10H13ClO2S 232.72700 |(zh) 232.03200 PSA 42.52000 LogP 3.56010
؛̖ | Ҏ(gu) | (sh) | r |
---|---|---|---|
Q-0111321 | 100mg |
1
|
ԃr |
Q-0111321 | 250mg |
1
|
ԃr |
Q-0111321 | 500mg |
1
|
ԃr |
Q-0111321 | 1g |
1
|
ԃr |
Q-0111321 | 5g |
1
|
ԃr |

(4---1-)-
Ӣ 4-chlorobutylsulfonylbenzene
ʽ C10H13ClO2S
232.72700
|(zh) 232.03200
PSA 42.52000
LogP 3.56010
P(gun)a(chn)Ʒ
2--3--5- CAS:124432-70-8
ɳs|(zh)C(}}) CAS:1243308-37-3
RN486 CAS:1242156-23-5
1H--3- CAS:1239363-47-3
(R)-(-)-4-sˮ CAS:123750-60-7
4--3,5-S CAS:123688-59-5
Prulifloxacin CAS:123447-62-1
27--99--9H- CAS:1229603-71-7
h(hun)ϩïF CAS:12260-67-2
B(ti)w/ĩ/Һ
a(chn)أ
rg1
棺
;
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָˣ | 95%+ |
ܽl | ЙC܄/ˮ |
CAS̖ | N/A |
N/A | |
l | -20ܹⱣ |
rg | 1 |
\ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
10--2,3,4,6,7,11B--1H-O[2,1-A] Ӣ 10-chloro-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline ʽ C12H15ClN2 222.71400 |(zh) 222.09200 PSA 15.27000
-
Ӣ 1'-[(2-methylpropan-2-yl)oxycarbonyl]spiro[3,4-dihydrochromene-2,4'-piperidine]-4-carboxylic acid ʽ C19H25NO5 347.40600 |(zh) 347.17300
-
N-S-N-2-(4-)Ұ Ӣ N-benzyl-2-morpholin-4-ylethanamine ʽ C13H20N2O 220.31100 |(zh) 220.15800 PSA 24.50000
-
3--4- Ӣ ethyl 3-iodo-4-morpholin-4-ylbenzoate ʽ C13H16INO3 361.17600 |(zh) 361.01700 PSA 38.77000 LogP 2.36950